Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of MDNA will rise by +15.61% over the next 2 Weeks and hit $0.18 by Thursday, January 30, 2025. In that time frame, MDNA's share price is expected to range between $0.11 and $0.25.
BearishAverageBullishMDNA shares remained flat 0 in Thursday, January 16, 2025's trading session, starting and closing at a previous close of $0.16 to move at $0.16. The stock demonstrated notable intraday movement (see MDNA's key stats for a full breakdown), fluctuating between $0.15 and $0.20, a +32.17% trading range. While recent weeks have seen some volatility, MDNA has managed to secure a -57.68% drop over the past 2 weeks. The neutral price movement was accompanied by increased trading volume, with approximately 1.26M shares changing hands, 1.2M more than the previous session. This amounted to $197.17K in total market activity.
Will MDNA Continue Its Upward Trend?
According to analyst ratings and projections for MDNA, Medicenna Therapeutics Corp. shares are anticipated to increase by +39.83%, potentially reaching $0.26 per share by January 30, 2025. Short-term technical indicators currently suggest a neutral sentiment for MDNA. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 13 positive trading days within the past 30 sessions. Based on the MDNA stock forecast, now is a good time to buy MDNA stock because its current trading price is -13.59% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on MDNA covering social and institutional perspectives.
MDNA Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into MDNA's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 56.09% to 59.65%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 50.19%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 47.42%, maintains a neutral outlook for the long term. Insights into MDNA's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Medicenna Therapeutics Corp. Monthly Forecast 2024
September 2024
According to our latest forecast models, Medicenna Therapeutics Corp. (MDNA) is positioned to show a strong performance in September 2024. The price is predicted to move between $0.00 and $0.36, settling at an average of $0.49. This could translate to a +212.10% gain.
October 2024
Based on current market signals, Medicenna Therapeutics Corp. is projected to trend october 2024. We forecast a trading range from $0.00 to $0.35, with a likely average price of $0.44. Investors could expect a potential return of +180.25%.
November 2024
Our predictive algorithms indicate Medicenna Therapeutics Corp. stock may see a shift in November 2024. The expected range spans $0.00–$0.14, with an average target of $0.28. This represents a positive outlook and a possible gain of +78.34%.
MDNA's history of dividends and stock splits also plays a role in long-term investor confidence.